The Rabies Diagnostics Market Segment focusing on the veterinary sector represents a critical, often volume-driven, component of the overall industry. Rabies remains a significant zoonotic threat, and the primary source of human infection worldwide is the domestic dog. Consequently, diagnostics in the veterinary segment are essential for three main purposes: surveillance, confirmation of suspected animal cases (which directly informs the need for human post-exposure prophylaxis), and testing for international animal movement/trade. The dominance of the dog population in transmitting the disease means that canine diagnostics are paramount, but testing also covers wildlife reservoirs like bats, raccoons, and foxes, particularly in rabies-free or well-controlled areas.

The preferred diagnostic method in the veterinary segment remains the post-mortem Direct Fluorescent Antibody Test (FAT) on brain tissue due to its reliability and speed. However, for surveillance and control programs, there is an increasing demand for rapid immunodiagnostic tests that are suitable for use in the field. Furthermore, serological tests, such as the Fluorescent Antibody Virus Neutralization (FAVN) test, are widely used to ensure pets moving internationally have adequate antibody titers following vaccination. The market is increasingly seeing innovations tailored for veterinary practices and mobile diagnostic units, underscoring the shift towards diagnostics as a proactive tool in disease prevention and control, rather than just a reactive tool for case confirmation.